Precision Engineering of Extracellular Vesicles as Programmable Carriers for mRNA Therapeutics

Area of Science:

• Biotechnology
• Nanomedicine
• Molecular Therapy

Background:

• Messenger RNA (mRNA) therapeutics show great potential but require effective delivery systems.
• Extracellular vesicles (EVs) are emerging as biocompatible, tissue-specific carriers for mRNA.
• Current delivery methods face challenges in efficiency, safety, and targeting.

Purpose of the Study:

• To comprehensively review engineering strategies for EV-based mRNA delivery.
• To evaluate advancements in EV loading, cargo control, and hybrid systems.
• To identify bottlenecks and future directions for clinical translation.

Main Methods:

• Review of exogenous loading (electroporation, lipid fusion, chemical/physical methods).
• Analysis of endogenous genetic engineering for programmable loading.
• Evaluation of hybrid EV-synthetic nanoparticle systems (e.g., cubosome-EVs).

Main Results:

• Engineered EVs demonstrate improved mRNA encapsulation and biodistribution.
• Hybrid systems show near-quantitative loading and enhanced blood-brain barrier penetration.
• Various loading and release mechanisms are being optimized.

Conclusions:

• EVs represent a powerful platform for mRNA therapeutic delivery.
• Further research is needed to address scalability, stability, and regulatory hurdles.
• Precision engineering of EVs holds promise for future clinical applications.